On July 18, 2022, AIM ImmunoTech Inc announced that it has received a notice from Jonathan Jorgl, nominating Robert Chioini and Michael Rice to the Company board. In addition, the Company stated that it filed a case against Jonathan Jorgl regarding the individuals have failed to register as a group pursuant to U.S. securities laws and have committed other unlawful actions in the context of their attempt to effectuate a takeover of the Company's Board.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.3727 USD | -4.44% | -9.19% | -15.28% |
06-05 | Transcript : AIM ImmunoTech Inc. - Special Call | |
05-16 | Transcript : AIM ImmunoTech Inc., Q1 2024 Earnings Call, May 16, 2024 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-15.28% | 21.29M | |
+15.20% | 121B | |
+19.67% | 113B | |
+18.95% | 26.02B | |
-23.86% | 19.39B | |
-19.03% | 15.91B | |
-20.90% | 15.09B | |
-46.14% | 15.06B | |
+63.85% | 14.93B | |
+4.49% | 13.85B |
- Stock Market
- Equities
- AIM Stock
- News AIM ImmunoTech Inc.
- AIM ImmunoTech Receives a Notice from Jonathan Jorgl